108 results
Page 3 of 6
8-K
EX-99.1
5knr2t2 edwg4i92sl
28 Feb 22
Arvinas Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:56pm
8-K
EX-99.2
vylwnp
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
u0pv57rbf 12ox
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
h8l3te7l qzcj
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
ylm9 4lckdyqn
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-99.1
kdbkp059yazxkmasp6rl
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
424B5
xyabv0p
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
5lb0442v
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
odt2xadwbqr5 ju3j
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-10.1
wuj7s3
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.2
rd4lq00t9dojr6x
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.3
rhvkqg76mr9 3ol
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
aha2b o0n2877lz
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
vogfu iqdl1q
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am